Interesting new research, early days. Not that significant re reducing Allele Burden but initial results appear promising re reducing reticulin fibrosis. Established drug with good tolerance profile.
Latest paper from Prof Harrison: Interesting new... - MPN Voice
Latest paper from Prof Harrison
Written by
Paul123456
To view profiles and participate in discussions please or .
5 Replies
•
Thanks for posting. In lay person language what does this mean for the MPN population of patients?
I’m not sure. Collagen fibrosity is of greater concern than Reticulin re MF. Will this work on Collagen? Whatever, it’s early days but appears a step in the right direction.
There is now a lot of research into MPNs after years of falling below the radar. Has to be highly encouraging re new treatment options within next few years. Evidently arsenic combined with Interferon has produced some great results, albeit in mice! Human trials next step.
Not what you're looking for?
You may also like...
Prof Claire Harrison shared ET paper via Twitter
https://www.sciencedirect.com/science/article/abs/pii/S0006497122080831
Summary Paper from Drs, Claire N. Harrison and Donal P. McLornan
Nice summary I just came across from some of the experts. I've included some outtakes I found...
New MPN Book by Prof. Claire Harrison.
Has anyone read “Managing MPNs” by Ruben Mesa & Prof. Claire Harrison.?
Prof Claire Harrison on significance of VAF monitoring
https://youtu.be/WifYlSTmWn4
Prof Harrison discussing significance of reducing % JAK2 AB
Many of us believe that using interferons to reduce JAK2 AB can yield a significant prognostic...